يعرض 1 - 10 نتائج من 19 نتيجة بحث عن '"SERUM ALANINE AMINOTRANSFERASE"', وقت الاستعلام: 1.08s تنقيح النتائج
  1. 1

    المصدر: Bollerup, S, Engsig, F, Hallager, S, Mocroft, A, Roege, B T, Christensen, P B, Laursen, A L, Krarup, H, Clausen, M R, Thielsen, P, Madsen, L G, Noerregaard, L, Barfod, T S, Balslev, U, Tarp, B, Hansen, J B, Mygind, L H, Gerstoft, J & Weis, N 2022, ' Incidence of Hepatocellular Carcinoma and Decompensated Liver Cirrhosis and Prognostic Accuracy of the PAGE-B HCC Risk Score in a Low Endemic Hepatitis B Virus Infected Population ', Journal of Hepatocellular Carcinoma, vol. 9, pp. 1093-1104 . https://doi.org/10.2147/JHC.S372571Test

    وصف الملف: text/html; application/pdf

  2. 2
  3. 3

    المصدر: Acta Pharmaceutica Sinica. B
    Acta Pharmaceutica Sinica B, Vol 11, Iss 1, Pp 89-99 (2021)

    مصطلحات موضوعية: GSTα, glutathianone S-transferase α, NAPQI, N-acetyl p-benzoquinone imine, AST, aspartate aminotransferase, Pharmacology, medicine.disease_cause, BrdU, bromodeoxyuridine, CDK4, cyclin-dependent kinase 4, 0302 clinical medicine, AAV, adeno-associated virus, ECL, electrochemiluminescence, GSTμ, glutathione S-transferase μ, GSH, glutathione, General Pharmacology, Toxicology and Pharmaceutics, HO-1, heme oxygenase-1, Liver injury, 0303 health sciences, Gene knockdown, biology, LDH, lactate dehydrogenase, Chemistry, CYP450, cytochromes P450, digestive, oral, and skin physiology, SIRT6, sirtuin 6, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Hepatocyte, Sirtuin, NRF2, nuclear factor erythroid 2-related factor 2, KEAP1, Kelch-like ECH-associated protein 1, Original Article, SIRT6, DNA damage, APAP, acetaminophen, ARE, antioxidant response element, NRF2, ALT, serum alanine aminotransferase, 03 medical and health sciences, H3K9ac, histone H3 Nε-acetyl-lysines 9, CCK-8, cell counting kit-8, ROS, reactive oxygen species, ALF, acute liver failure, Dox, doxorubicin, H3K56ac, histone H3 Nε-acetyl-lysines 56, medicine, Viability assay, 030304 developmental biology, Acetaminophen, P53, CCND1, cyclin D1, lcsh:RM1-950, Hepatotoxicity, medicine.disease, BCA, bicinchoninic acid, lcsh:Therapeutics. Pharmacology, DCF, dichlorofluorescein, siRNA, small interfering RNA, biology.protein, H&E, hematoxylin and eosin, CCNA1, cyclin A1, NQO1, NAD(P)H quinone dehydrogenase 1, Co-IP, co-immunoprecipitation, Oxidative stress

  4. 4

    المساهمون: Francque, Sven M, Marchesini, Giulio, Kautz, Achim, Walmsley, Martine, Dorner, Rebecca, Lazarus, Jeffrey V, Zelber-Sagi, Shira, Hallsworth, Kate, Busetto, Luca, Frühbeck, Gema, Dicker, Dror, Woodward, Euan, Korenjak, Marko, Willemse, José, Koek, Gerardus H, Vinker, Shlomo, Ungan, Mehmet, Mendive, Juan M, Lionis, Christos, Interne Geneeskunde, MUMC+: MA Maag Darm Lever (9), RS: NUTRIM - R2 - Liver and digestive health

    المصدر: JHEP Reports
    JHEP Reports, Vol 3, Iss 5, Pp 100322-(2021)
    JHEP Reports, 3(5):100322. Elsevier BV

    مصطلحات موضوعية: NASH, non-alcoholic steatohepatiti, Y GASTRIC BYPASS, Disease, RC799-869, PLACEBO-CONTROLLED TRIAL, LIFE-STYLE MODIFICATION, cardiovascular disease, LDL, low-density lipoprotein, HEPATOCELLULAR-CARCINOMA, non-invasive test, T2D, GLP-1 RAs, glucagon-like receptor 1 agonists, European Association for the Study of Obesity, HCC, Gastroenterology, NASH, specific, Diseases of the digestive system. Gastroenterology, CAP, controlled attenuation parameter, CT, computed tomography, FXR, ASH, alcoholic steatohepatitis, GP, non-alcoholic steatohepatitis, GLP-1 RAs, glucagon-like receptor 1 agonist, LDL, low-density lipoproteins, medicine.medical_specialty, HDL, achievable, NASH, non-alcoholic steatohepatitis, T2D, type 2 diabetes, high-density lipoprotein, CVD, cardiovascular disease, LDL, Patient Guideline, Quality of life (healthcare), FXR, farnesoid X receptor, NAFLD, low-density lipoproteins, GP, general practitioner, NAFL, non-alcoholic fatty liver, FIB-4, fibrosis-4 index, Intensive care medicine, computed tomography, Guideline, medicine.disease, T1D, type 1 diabete, digestive system diseases, NIT, Human medicine, farnesoid X receptor, type 1 diabetes, BMI, body mass index, EASL, European Association for the Study of the Liver, Placebo-controlled study, Chronic liver disease, GLP-1 RAs, QUALITY-OF-LIFE, alcoholic steatohepatitis, European Association for the Study of Diabetes, EASD, European Association for the Study of Diabetes, Immunology and Allergy, magnetic resonance imaging, NASH Clinical Research Network, ALD, alcohol-related or alcoholic liver disease, Disease management (health), glucagon-like receptor 1 agonists, EASO, European Association for the Study of Obesity, NASH CRN, NASH Clinical Research Network, ASH, alcoholic steatohepatiti, Fatty liver, timely, hepatocellular carcinoma, CVD, magnetic resonance elastography, MRE, NAFL, FIB-4, non-alcoholic fatty liver, type 2 diabetes, T1D, type 1 diabetes, CAP, controlled attenuation parameter, CT, European Association for the Study of the Liver, MRI, fibrosis-4 index, NAFLD, non-alcoholic fatty liver disease, EASD, HDL, high-density lipoprotein, UNITED-STATES, ASH, body mass index, EASL, measurable, BMI, NIT, non-invasive test, Internal Medicine, medicine, NASH CRN, HEPATIC STEATOSIS, HCC, hepatocellular carcinoma, MRE, magnetic resonance elastography, MRI, magnetic resonance imaging, SMART, specific, measurable, achievable, relevant, timely, Disease burden, BARIATRIC SURGERY, Hepatology, SMART, business.industry, SERUM ALANINE AMINOTRANSFERASE, non-alcoholic fatty liver disease, PHYSICAL-ACTIVITY, alcohol-related or alcoholic liver disease, EASD, European Association for the Study of Diabete, EASO, ALD, general practitioner, relevant, T1D, business

    وصف الملف: ELETTRONICO

  5. 5
  6. 6
  7. 7

    المصدر: Toxicology Reports, Vol 5, Iss, Pp 146-155 (2018)
    Toxicology Reports

  8. 8
  9. 9

    المؤلفون: LI Bing

    المصدر: Linchuang Gandanbing Zazhi, Vol 30, Iss 5, Pp 413-416 (2014)

    مصطلحات موضوعية: ObjectiveTo analyze the clinical features and laboratory test results of patients with autoimmune hepatitis (AIH)-primary biliary cirrhosis (PBC) overlap syndrome, laboratory test results, the correct diagnosis rate was the lowest (52.83%), and multiple comparisons were made by SNK-q test, comparison of qualitative data between groups was made using R×C contingency table, and it took the longest time (8±7.7 d) to confirm the diagnosis on admission. ConclusionThe clinical manifestations of patients with AIH-PBC overlap syndrome are more similar to those of PBC patients, but their biochemical test results are more similar to those of AIH patients. AIH-PBC overlap syndrome has the clinical features of both AIH and PBC, digestive system diseases, as well as their correct diagnosis rate and time to diagnosis. MethodsFifty-three patients who were diagnosed by liver biopsy as having AIH-PBC overlap syndrome from January 2009 to June 2013 were selected as subjects, 53 AIH patients and 53 PBC patients were selected as control groups. Their clinical manifestations, 27 were positive for anti-mitochondrial antibody-M2, a serum total bilirubin level of 38.07±6.82 μmol/L, and a serum gamma-glutamyl transpeptidase level of 57.57±78.84 U/L. ALP showed significant difference between the patients with AIH-PBC overlap syndrome and control groups. The serum level of immunoglobulin M in overlap syndrome patients was 3.33±2.12 g/L, which was significantly different from those of two control groups. Of the 53 overlap syndrome patients, and the positive rate was significantly different from those of two control groups. Without liver biopsy, and diagnosis on admission were retrospectively analyzed. Comparison of normally distributed quantitative data between groups was made by one-way analysis of variance, lcsh:Diseases of the digestive system. Gastroenterology, lcsh:RC799-869, and multiple comparisons were made by Scheffe′s confidence interval test. ResultsThe 53 patients with AIH-PBC overlap syndrome had a serum alanine aminotransferase level of 173.65±52.08 U/L, a serum alkaline phosphatase (ALP) level of 293.81±28.89 U/L

  10. 10

    المصدر: International Journal of Environmental Research and Public Health, Vol 13, Iss 9, p 841 (2016)
    International Journal of Environmental Research and Public Health; Volume 13; Issue 9; Pages: 841
    International Journal of Environmental Research and Public Health

    وصف الملف: application/pdf